Toth Financial Advisory’s Roivant Sciences ROIV Stock Holding History

Toth Financial Advisory’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.6K	Buy	400 +300	+300%	+$10.9K	﹤0.01%	546
2026 Q2	$3.54K	Sell	100 -50	-33%	-$1.48K	﹤0.01%	690
2026 Q1	$4.16K	Hold	150	–	–	﹤0.01%	658
2025 Q4	$3.25K	Hold	150	–	–	﹤0.01%	669
2025 Q3	$2.27K	Hold	150	–	–	﹤0.01%	682
2025 Q2	$1.69K	Hold	150	–	–	﹤0.01%	657
2025 Q1	$1.51K	Hold	150	–	–	﹤0.01%	628
2024 Q4	$1.77K	Sell	150 -120	-44%	-$1.42K	﹤0.01%	599
2024 Q3	$3.12K	Buy	270 +120	+80%	+$1.37K	﹤0.01%	551
2024 Q2	$1.59K	Hold	150	–	–	﹤0.01%	636
2024 Q1	$1.58K	Buy	+150	New	+$1.62K	﹤0.01%	634

Other funds holding ROIV

TSC

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

FFAS

FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return

LWA

Ledgewood Wealth Advisors Exeter, New Hampshire $181M AUM 9.93% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

AIM

Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return

Toth Financial Advisory's ROIV Position: Q3 2026 in Review

Toth Financial Advisory increased its Roivant Sciences (ROIV) stake by 300% in Q3 2026, buying an estimated $10.9K and bringing the position to 400 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #546.

Toth Financial Advisory first reported a position in ROIV in Q1 2024 and has held it in 11 quarters since. 20 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

Toth Financial Advisory held 400 shares of Roivant Sciences worth $14.6K as of Q3 2026.
Toth Financial Advisory bought 300 Roivant Sciences shares in Q3 2026, an estimated $10.9K.
Roivant Sciences made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #546 holding.
Toth Financial Advisory first reported a position in Roivant Sciences in Q1 2024 and has held it in 11 quarters since.
20 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.